ArticleJournal of the advanced practitioner in oncology2020

Polatuzumab Vedotin for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Transplant-Ineligible Patients.

Melanie DouglasPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.